Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Drug Name | Talacotuzumab |
| Trade Name | |
| Synonyms | JNJ-56022473|CSL362|JNJ-473 |
| Drug Descriptions |
Talacotuzumab (JNJ-56022473) is a monoclonal antibody directed against CD123 (IL3RA), which may increase antibody-dependent cell-mediated cytoxicity of CD123 (IL3RA)-expressing tumor cells (Blood Dec 2015, 126 (23) 4946). |
| DrugClasses | CD123 (IL3RA) Antibody 14 |
| CAS Registry Number | 1826831-79-1 |
| NCIT ID | C102784 |
| Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
|---|---|---|---|
| Decitabine + Talacotuzumab | Decitabine Talacotuzumab | 0 | 1 |
| Talacotuzumab | Talacotuzumab | 0 | 1 |